Cellcast Technologies, LLC v. United States

CourtUnited States Court of Federal Claims
DecidedFebruary 25, 2021
Docket15-1307
StatusPublished

This text of Cellcast Technologies, LLC v. United States (Cellcast Technologies, LLC v. United States) is published on Counsel Stack Legal Research, covering United States Court of Federal Claims primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Cellcast Technologies, LLC v. United States, (uscfc 2021).

Opinion

In the United States Court of Federal Claims No. 15-1307 25 February 2021

*************************************** CELLCAST TECHNOLOGIES, * LLC AND ENVISIONIT, LLC, * * Plaintiffs, * Patent Infringement; RCFC 16(b)(4); * Good Cause; Modification of v. * Scheduling Order; Amend Infringement * Contentions; Fact Discovery. THE UNITED STATES, * * Defendant, * * and * * INTERNATIONAL BUSINESS * MACHINES CORP., * * Third-party defendant * * ***************************************

Peter J. Chassman, with whom was Michael Forbes, Reed Smith LLP, Houston, TX, for plaintiffs.

Joshua Miller, Walter Brown, and Carrie E. Rosato, Trial Attorneys, with whom were Joseph H. Hunt, Assistant Attorney General, and Gary L. Hausken, Director, Commercial Litigation Branch, Civil Division, Department of Justice, Washington, DC, for defendant.

Mark Joseph Abate, with whom were Dietrich Brown, Calvin E. Wingfield Jr., Shaun de Lacy, and Alexandra D. Valenti, Goodwin Procter, LLP, New York, NY, for third-party defendant. OPINION AND ORDER

HOLTE, Judge.

Plaintiffs accuse the government of infringing five United States patents. The government noticed the licensed developers of the technology, International Business Machines Corporation, who join the government in defending the claims of patent infringement. The parties completed fact discovery on 11 May 2018. The Court issued a claim construction order on 26 October 2020.1 On 11 November 2020, plaintiffs filed an Expedited Motion for Leave to Amend Infringement Contentions, which defendants oppose. For the following reasons, the Court GRANTS plaintiffs’ Expedited Motion for Leave to Amend Infringement Contentions.

I. Overview

EnvisionIT is the assignee of five United States patents: 7,693,938 (“the ‘938 patent”); 8,103,719 (“the ‘719 patent”); 8,438,221; 8,438,212; and 9,136,954 (collectively, “the asserted patents”). Pls.’ Compl. ¶ 18. CellCast holds an exclusive license to each of the asserted patents. Id. ¶ 19. Plaintiffs allege various government agencies infringe the asserted patents, including the Federal Emergency Management Agency, the United States Department of Homeland Security, and the National Oceanic and Atmospheric Administration. Id. ¶ 5.

The Integrated Public Alert Warning System (“IPAWS”) is among the technology alleged to infringe the asserted patents. Id. ¶ 20. According to the government, International Business Machines (“IBM”) developed IPAWS under a government contract. See Gov’t’s Unopp. Mot. to Notice Third Party at 2, ECF No. 10. The government noticed IBM pursuant to Rule 14(b) of the Rules of the United States Court of Federal Claims (“RCFC”) and IBM entered the case. See generally IBM’s Ans., ECF No. 21. Hereinafter, the government and IBM are collectively referred to as “defendants,” and IBM, when acting alone, is referred to as “third- party defendant.”

Pursuant to this Court’s 23 February 2018 Order, fact discovery closed on 11 May 2018. See Order, ECF No. 92. This case was transferred to the undersigned Judge on 29 July 2019 pursuant to RCFC 40.1(c). See Order, ECF No. 149. The Court issued a claim construction order on 26 October 2020, in which the Court adopted defendants’ construction for the term “broadcast message originator/broadcast agent” term and ruled against plaintiffs when finding the disputed terms in claims 1 and 11–13 of the ’938 patent” were means-plus-function terms. See Op. and Order at 21, 47 (“Cl. Constr. Order”), ECF No. 162.

The Court’s claim construction crder prompted plaintiffs’ Expedited Motion for Leave to Amend Infringement Contentions (“Pls.’ Mot. for Leave”), ECF No. 163, which is currently pending before the Court.

II. Procedural and Factual History

1 The Court issued the claim construction order under seal on 26 October 2020 and reissued the Order for publication in its original form on 29 October 2020 after neither party proposed redactions.

-2- On 11 July 2016, the parties submitted a Joint Preliminary Status Report setting forth certain rules and dates for the management of this patent case. See Joint Prelim. Status Report, ECF No. 28 (“July 2016 JPSR”). The schedule was modeled in part on the Special Procedures Order for Cases under 28 U.S.C. § 1498(a), which was originally adopted by Senior Judge Damich in Holmberg v. United States, No. 14-cv-284 (Fed. Cl. June 10, 2014), ECF No. 7. Id. at 10. Pursuant to the 23 February 2018 Order, fact discovery closed on 11 May 2018. See Order, ECF No. 92. The parties nevertheless amended the schedule several times. For example, on 26 April 2018 third party defendant amended its Answer without plaintiffs’ opposition. See Am. Answer of International Business Machines Corporation, ECF No. 96. In addition, on 13 November 2019, the Court admitted defendants’ amended invalidity contentions after close of fact discovery and reopened fact discovery for defendants as to a third party for good cause. See Op. and Order (“November 2019 Order”), ECF No. 155.

The Court issued a claim construction order on 26 October 2020. See Cl. Constr. Order. On 30 October 2020, the parties began negotiations on a reduction of asserted claims and amending infringement contentions in view of the Court’s claim construction order. See Pls.’ Mot. for Leave at 3. On 11 November 2020, after the parties failed to reach any agreement, plaintiffs filed a motion seeking the Court’s leave to amend infringement contentions. See id. at 5. Defendants filed an opposition to plaintiffs’ motion on 18 November 2020, and plaintiffs filed a reply to defendants’ opposition on 20 November 2020. See Defs.’ Opp’n to Pls.’ Expedited Mot. for Leave to Amend Infringement Contentions, ECF No. 168 (“Defs.’ Opp’n”); Pls’ Reply in Supp. of Expedited Mot. for Leave to Amend Infringement Contentions, ECF No. 169 (“Pls.’ Reply”).

On 24 November 2020, the Court held a status conference to discuss plaintiffs’ motion and other pending motions in the case. See Transcript, ECF No. 171 (“Tr. I”). Despite the Court’s efforts to resolve the disputes between the parties, defendants declined to consent on plaintiffs’ amended contentions and maintained the Court rule on plaintiffs’ motion. Id. at 43:11–13. The Court held oral argument on 8 December 2020. See Transcript, ECF No. 174 (“Tr. II”). The case is stayed pending resolution of the dispute on plaintiffs’ amended infringement contentions. See Order, ECF No. 167.

III. Parties’ Arguments

Plaintiffs contend “[t]he [i]ssuance of a [c]laim [c]onstruction [r]uling [p]rovides [g]ood [c]ause for [a]mendment.” Pls.’ Mot. for Leave at 5. In support, plaintiffs cite local patent rules from numerous district courts. Id. For example, Patent Local Rule 3-6 rule of the Northern District of California provides “a finding of good cause [for amendment of infringement contentions] include: (a) A claim construction by the Court different from that proposed by the party seeking amendment.” Id. at 6 (citing U.S. District Court for the Northern District of California Patent L.R. 3-6.).

According to plaintiffs, the parties conferred regarding the amended infringement contentions on the following timeline: on 30 October 2020, plaintiffs told defendants plaintiffs wanted to discuss amending the infringement contentions; on 3 November 2020, plaintiffs

-3- provided an exemplary amended infringement contention to defendants; on 8 November 2020, plaintiffs emailed defendants “a complete set of all proposed amendments concerning both the ‘broadcast agent/broadcast message originator’ term and . . . the means-plus-function terms”; and the parties conferred on 9 November 2020 and were unable to reach an agreement. See id. at 3– 5.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Kruse Technology Partnership v. Volkswagen Ag
544 F. App'x 943 (Federal Circuit, 2013)
Nike, Inc. v. ADIDAS AMERICA INC.
479 F. Supp. 2d 664 (E.D. Texas, 2007)
MediaCom Corp. v. Rates Technology, Inc.
4 F. Supp. 2d 17 (D. Massachusetts, 1998)
Linex Technologies, Inc. v. Belkin International, Inc.
628 F. Supp. 2d 703 (E.D. Texas, 2008)
Finisar Corp. v. DirecTV Group, Inc.
424 F. Supp. 2d 896 (E.D. Texas, 2006)
MacNeill Engineering Co., Inc. v. Trisport, Ltd.
126 F. Supp. 2d 51 (D. Massachusetts, 2001)
Amgen, Inc. v. Hoechst Marion Roussel, Inc.
126 F. Supp. 2d 69 (D. Massachusetts, 2001)
Realtime Data, LLC v. Morgan Stanley
554 F. App'x 923 (Federal Circuit, 2014)
Keranos, LLC v. Silicon Storage Technology, Inc.
797 F.3d 1025 (Federal Circuit, 2015)
Morphotrust USA, LLC v. United States
132 Fed. Cl. 419 (Federal Claims, 2017)

Cite This Page — Counsel Stack

Bluebook (online)
Cellcast Technologies, LLC v. United States, Counsel Stack Legal Research, https://law.counselstack.com/opinion/cellcast-technologies-llc-v-united-states-uscfc-2021.